Valuation: ALTEOGEN Inc.

Market Cap 18,077B 11.93B 10.44B 9.62B 8.92B 16.93B 1,133B 17.21B 115B 44.88B 559B 44.8B 43.83B 1,932B P/E 2026 *
61.7x
P/E 2027 * 41.4x
Enterprise Value 17.58B 11.6M 10.16M 9.36M 8.67M 16.47M 1.1B 16.73M 112M 43.64M 544M 43.57M 42.62M 1.88B EV / Sales 2026 *
37.5x
EV / Sales 2027 * 25.7x
Free-Float
74.26%
Yield 2026 *
0.15%
Yield 2027 * 0.16%
1 day+1.96%
1 week-9.52%
Current month-6.51%
1 month+1.50%
3 months-6.77%
6 months-28.80%
Current year-24.92%
1 week 325,000
Extreme 325000
381,500
1 month 286,000
Extreme 286000
397,500
Current year 286,000
Extreme 286000
529,000
1 year 286,000
Extreme 286000
569,000
3 years 38,000
Extreme 38000
569,000
5 years 27,875
Extreme 27875
569,000
10 years 3,645.83
Extreme 3645.8333
569,000
Manager TitleAgeSince
Chief Executive Officer 60 2025-12-25
Director of Finance/CFO 61 2023-03-27
Corporate Officer/Principal - -
Director TitleAgeSince
Chairman 71 2008-05-12
Director/Board Member 70 2021-03-28
Director/Board Member 61 2023-03-27
Date Insider Type Main position Quantity % Market Cap.
25-05-20Fiscal year

Chief Executive Officer

7,200 0.0135%
24-03-26Sell 1,600,000 3.0182%
24-01-04Sell 6,000 0.0115%
Change 5-day change 1-year change 3-year change Capi.($)
+1.96%-9.52%-10.12%+766.50% 11.93B
+4.07%+8.45%+25.67%-2.34% 68.8B
-0.91%-2.48%+47.85%+220.63% 55.21B
+1.21%+42.20%+42.20%+42.20% 43.46B
+0.27%+8.33%-49.87%-53.43% 41.18B
-2.48%+13.91%+166.79%-32.89% 31.65B
-1.32%-4.79%+58.07%-25.22% 30.37B
+2.10%+4.14%+75.49%+90.19% 23.58B
-1.15%+8.29%+4.42%+184.96% 19.33B
-1.31%+2.34%+65.31%+132.45% 17.16B
Average +0.21%+3.29%+42.58%+132.30% 34.27B
Weighted average by Cap. +0.57%+3.84%+41.14%+78.70%

Financials

2026 *2027 *
Net sales 469B 309M 271M 250M 231M 439M 29.37B 446M 2.99B 1.16B 14.49B 1.16B 1.14B 50.1B 672B 444M 388M 358M 332M 630M 42.11B 640M 4.29B 1.67B 20.78B 1.67B 1.63B 71.84B
Net income 311B 205M 179M 165M 153M 291M 19.47B 296M 1.98B 771M 9.61B 770M 753M 33.2B 397B 262M 229M 211M 196M 372M 24.85B 377M 2.53B 985M 12.26B 983M 962M 42.39B
Net Debt -499B -329M -288M -266M -246M -467M -31.25B -475M -3.18B -1.24B -15.42B -1.24B -1.21B -53.31B -828B -546M -478M -441M -408M -775M -51.86B -788M -5.28B -2.05B -25.59B -2.05B -2.01B -88.46B
Logo ALTEOGEN Inc.
Alteogen Inc is a Korea-based company primarily engaged in the research, development, and sales of biopharmaceuticals. The Company develops, produces, and sells biopharmaceuticals, including biobetters and novel biopharmaceuticals, based primarily on hyaluronidase protein engineering technology, sustained-release biopharmaceutical technology, and next-generation antibody-drug conjugate technology. In addition, the Company is engaged in research, development, and commercialization of biosimilars.
Employees
172
Date Price Change Volume
26-07-07 ₩337,500.00 +1.96% 355,590
26-07-06 ₩331,000.00 -3.07% 266,040
26-07-03 ₩341,500.00 -2.84% 439,497
26-07-02 ₩351,500.00 -1.82% 392,958
26-07-01 ₩358,000.00 -0.83% 439,869
Trader
Investor
Global
Quality
ESG MSCI
CCC
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
337,500.00KRW
Average target price
458,000.00KRW
Spread / Average Target
+35.70%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A196170 Stock